Clinical Trial Update: Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on the safety and tolerability of BION-1301 in healthy volunteers and adults with IgA nephropathy (IgAN) across Phase 1 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• BION-1301

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: IgA Nephropathy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING